Filtered By:
Specialty: Urology & Nephrology
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 98061 results found since Jan 2013.
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer
CONCLUSIONS: In ERBT, surgeon's experience seems irrelevant to obtain DM. Resection quality relies on surgical margin status, not the degree of DM. Obtaining excessive DM incurs adverse events/unnecessary medical care.PMID:37714725 | DOI:10.1016/j.urolonc.2023.08.004
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Takafumi Yanagisawa Shun Sato Yasushi Hayashida Yohei Okada Wataru Fukuokaya Kosuke Iwatani Akihiro Matsukawa Masayuki Shimoda Hiroyuki Takahashi Takahiro Kimura Shahrokh F Shariat Jun Miki Source Type: research
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer
CONCLUSIONS: In ERBT, surgeon's experience seems irrelevant to obtain DM. Resection quality relies on surgical margin status, not the degree of DM. Obtaining excessive DM incurs adverse events/unnecessary medical care.PMID:37714725 | DOI:10.1016/j.urolonc.2023.08.004
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Takafumi Yanagisawa Shun Sato Yasushi Hayashida Yohei Okada Wataru Fukuokaya Kosuke Iwatani Akihiro Matsukawa Masayuki Shimoda Hiroyuki Takahashi Takahiro Kimura Shahrokh F Shariat Jun Miki Source Type: research
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Malignancy-associated membranous nephropathy: focus on diagnosis and treatment
CONCLUSIONS: Tumor screening is important in patients with membranous nephropathy, especially in elderly patients and patients with negative phospholipase A2 receptor or non-IgG4 predominant deposition. Remission of membranous nephropathy can be observed following remission of cancer in some cases. Immunosuppressive therapy may be considered if membranous nephropathy does not remit after remission of cancer.PMID:37713160 | DOI:10.1007/s40620-023-01751-4
Source: Journal of Nephrology - September 15, 2023 Category: Urology & Nephrology Authors: SanXi Ai XiWei Yan XueSong Zhao WenLing Ye YuBing Wen Jing Wang BoJu Pan Jie Dong XueMei Li Yan Qin Source Type: research
Characteristics of Complement Protein Deposition in Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposition
CONCLUSIONS: The complement system was found to be overactivated in PGNMID, and levels of urinary complements correlated with disease severity. A higher level of urinary C4d was identified as an independent risk factor for kidney failure.PMID:37713183 | DOI:10.2215/CJN.0000000000000295
Source: Clinical Journal of the American Society of Nephrology : CJASN - September 15, 2023 Category: Urology & Nephrology Authors: Meng-Yao Liu Xiao-Juan Yu Su-Xia Wang Yuan Li Guolan Xing Ming Chen Fu-de Zhou Ming-Hui Zhao Source Type: research
LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients
CONCLUSIONS: Subclassification of IR prostate cancer into FIR and UIR subcategories appears mandatory. For FIR patients, outcomes after BT monotherapy were acceptable. However, clinical failure after 125J-LDR-BT in UIR patients was notably increased, suggesting that BT monotherapy was less successful in this risk group. In contrast, the outcome in UIR patients after CRT was excellent.PMID:37714724 | DOI:10.1016/j.urolonc.2023.08.007
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Andreas Boehle Dorothea Zywietz Irina Robrahn-Nitschke Achim Lusch Inke R K önig Source Type: research
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer
CONCLUSIONS: In ERBT, surgeon's experience seems irrelevant to obtain DM. Resection quality relies on surgical margin status, not the degree of DM. Obtaining excessive DM incurs adverse events/unnecessary medical care.PMID:37714725 | DOI:10.1016/j.urolonc.2023.08.004
Source: Urologic Oncology - September 15, 2023 Category: Urology & Nephrology Authors: Takafumi Yanagisawa Shun Sato Yasushi Hayashida Yohei Okada Wataru Fukuokaya Kosuke Iwatani Akihiro Matsukawa Masayuki Shimoda Hiroyuki Takahashi Takahiro Kimura Shahrokh F Shariat Jun Miki Source Type: research
Incidence of urological tumors in Down ’s syndrome: a systematic review and meta-analysis
ConclusionThere was a very low incidence of urological tumors in people with Down ’s syndrome. Testis tumor was the most frequently described in all cohorts and within a normal distribution range.
Source: International Urology and Nephrology - September 14, 2023 Category: Urology & Nephrology Source Type: research
Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis
ConclusionsThis meta-analysis shows that PLA2R-AB and THSD7A-AB are of important diagnostic value for IMN. More studies are needed in the future to reveal the diagnostic value of LIMP-2 and circRNAs for IMN.
Source: International Urology and Nephrology - September 14, 2023 Category: Urology & Nephrology Source Type: research
Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis
Clin J Am Soc Nephrol. 2023 Sep 14. doi: 10.2215/CJN.0000000000000323. Online ahead of print.NO ABSTRACTPMID:37707829 | DOI:10.2215/CJN.0000000000000323
Source: Clinical Journal of the American Society of Nephrology : CJASN - September 14, 2023 Category: Urology & Nephrology Authors: Vivek Charu Lu Tian Manjula Kurella-Tamura Maria E Montez-Rath Source Type: research
Keep Seeking the Holy Grail: Predictive Modeling of Arteriovenous Fistula Maturation and Survival
Clin J Am Soc Nephrol. 2023 Sep 14. doi: 10.2215/CJN.0000000000000293. Online ahead of print.NO ABSTRACTPMID:37707823 | DOI:10.2215/CJN.0000000000000293
Source: Clinical Journal of the American Society of Nephrology : CJASN - September 14, 2023 Category: Urology & Nephrology Authors: Haimanot Wasse Dirk M Hentschel Source Type: research
Vascular Access-Related Distal Ischemia Requiring Intervention: Frequency, Risk Factors, and Consequences
CONCLUSIONS: Access-related distal ischemia requiring intervention was rare in the current study, and more common in women and patients with peripheral vascular disease or coronary artery disease. In some cases, a subsequent vascular access could be placed with a low likelihood of recurrent distal ischemia.PMID:37707801 | DOI:10.2215/CJN.0000000000000310
Source: Clinical Journal of the American Society of Nephrology : CJASN - September 14, 2023 Category: Urology & Nephrology Authors: Michael Allon Gary R Cutter Carlton J Young Source Type: research
